Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer (Q36166836)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer |
scientific article |
Statements
1 reference
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer (English)
1 reference
C Nabhan
1 reference
D Villines
1 reference
T V Valdez
1 reference
K Tolzien
1 reference
T M Lestingi
1 reference
J D Bitran
1 reference
S M Christner
1 reference
M J Egorin
1 reference
J H Beumer
1 reference
17 July 2012
1 reference
1 reference
592-597
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference